BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 15088296)

  • 1. Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95.
    Björnådal L; Yin L; Granath F; Klareskog L; Ekbom A
    J Rheumatol; 2004 Apr; 31(4):713-9. PubMed ID: 15088296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964-95.
    Björnådal L; Baecklund E; Yin L; Granath F; Klareskog L; Ekbom A
    J Rheumatol; 2002 May; 29(5):906-12. PubMed ID: 12022348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes of death in patients with celiac disease in a population-based Swedish cohort.
    Peters U; Askling J; Gridley G; Ekbom A; Linet M
    Arch Intern Med; 2003 Jul; 163(13):1566-72. PubMed ID: 12860579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and mortality of systemic lupus erythematosus in a southern Chinese population, 2000-2006.
    Mok CC; To CH; Ho LY; Yu KL
    J Rheumatol; 2008 Oct; 35(10):1978-82. PubMed ID: 18688913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden.
    Uddhammar A; Eriksson AL; Nyström L; Stenling R; Rantapää-Dahlqvist S
    J Rheumatol; 2002 Apr; 29(4):737-42. PubMed ID: 11950015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years.
    Urowitz MB; Gladman DD; Abu-Shakra M; Farewell VT
    J Rheumatol; 1997 Jun; 24(6):1061-5. PubMed ID: 9195509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term mortality rate in rheumatoid arthritis patients with disease onset in the 1980s.
    Kapetanovic MC; Lindqvist E; Geborek P; Saxne T; Eberhard K
    Scand J Rheumatol; 2011 Nov; 40(6):433-8. PubMed ID: 21619489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis.
    Ståhl-Hallengren C; Jönsen A; Nived O; Sturfelt G
    J Rheumatol; 2000 Mar; 27(3):685-91. PubMed ID: 10743809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study.
    Bengtsson C; Ohman ML; Nived O; Rantapää Dahlqvist S
    Lupus; 2012 Apr; 21(4):452-9. PubMed ID: 22065097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus.
    Zonana-Nacach A; Yañez P; Jiménez-Balderas FJ; Camargo-Coronel A
    Lupus; 2007; 16(12):997-1000. PubMed ID: 18042596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden.
    Wallberg-Jonsson S; Ohman ML; Dahlqvist SR
    J Rheumatol; 1997 Mar; 24(3):445-51. PubMed ID: 9058647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cohort study linked increased mortality in patients treated surgically for Dupuytren's contracture.
    Wilbrand S; Ekbom A; Gerdin B
    J Clin Epidemiol; 2005 Jan; 58(1):68-74. PubMed ID: 15649673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus.
    Borchers AT; Keen CL; Shoenfeld Y; Gershwin ME
    Autoimmun Rev; 2004 Aug; 3(6):423-53. PubMed ID: 15351310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, predictors and outcome of vascular damage in systemic lupus erythematosus.
    Becker-Merok A; Nossent J
    Lupus; 2009 May; 18(6):508-15. PubMed ID: 19395452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study.
    Hooning MJ; Aleman BM; van Rosmalen AJ; Kuenen MA; Klijn JG; van Leeuwen FE
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1081-91. PubMed ID: 16446057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death.
    Abu-Shakra M; Urowitz MB; Gladman DD; Gough J
    J Rheumatol; 1995 Jul; 22(7):1259-64. PubMed ID: 7562755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term prognosis and causes of death in systemic lupus erythematosus.
    Doria A; Iaccarino L; Ghirardello A; Zampieri S; Arienti S; Sarzi-Puttini P; Atzeni F; Piccoli A; Todesco S
    Am J Med; 2006 Aug; 119(8):700-6. PubMed ID: 16887417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality outcomes in pediatric rheumatology in the US.
    Hashkes PJ; Wright BM; Lauer MS; Worley SE; Tang AS; Roettcher PA; Bowyer SL
    Arthritis Rheum; 2010 Feb; 62(2):599-608. PubMed ID: 20112378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term cause-specific mortality among five-year survivors of childhood cancer.
    Cardous-Ubbink MC; Heinen RC; Langeveld NE; Bakker PJ; Voûte PA; Caron HN; van Leeuwen FE
    Pediatr Blood Cancer; 2004 Jun; 42(7):563-73. PubMed ID: 15127410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus.
    Ward MM
    Arthritis Rheum; 1999 Feb; 42(2):338-46. PubMed ID: 10025929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.